Sophia Genetics introduced Sophia DDM Digital Twins, an AI‑powered module within its Sophia DDM cloud platform that builds computational replicas of individual patients using multimodal clinical, genomic, imaging and pathology data. Announced at ESMO, the research‑use‑only tool is pitched to accelerate translational research, simulate treatment responses and enhance trial matching across the Unity network of de‑identified data contributors. Company CEO Jurgi Camblong framed the product as a step toward predictive oncology; Sophia stresses Digital Twins is RUO and requires additional validation before clinical use. The launch highlights growing vendor efforts to integrate genomics, longitudinal clinical records and AI to model disease trajectories at scale.